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Abstract
Background: Recombinant adenoviral vectors are highly efficient for in vitro and in vivo gene
delivery. They can easily be produced in large numbers, transduce a wide variety of cell types and
generate high levels of transgene expression.
The AdEasy system is a widely used system for generating recombinant adenoviral vectors, which
are created with a minimum of enzymatic manipulations and by employing homologous
recombination in E. coli.
In this paper we describe an alternative simplified method for screening recombinant DNA within
the AdEasy system. This Duplex-PCR-method is independent of the transgene or insert and can be
used for the complete AdEasy system. It is characterized by a simple standard protocol and the
results can be obtained within a few hours. The PCR is run with two different primer sets. The
primers KanaFor and KanaRev hybridizise with the Kanamycin resistence gene and AdFor and
AdRev detect the adenoviral backbone. In case of recombinant clones, two diagnostic fragments
with a size of 384 bp and 768 bp are generated.
Results: The practicability of this method was verified with three different transgenes: Cytosin
Deaminase (AdCD), p53 (Adp53) and Granulocyte Macrophage Colony Stimulating Factor (AdGM-
CSF). Recombinant clones are indicated by two diagnostic fragments and are then suitable for
further processing.
Conclusion: In summary, the presented protocol allows fast detection of recombinants with an
easy technique by minimizing the amount of necessary steps for generating a recombinant
adenovirus. This method is time sparing and cost-effective.
Background
Recombinant adenoviral vectors are highly efficient for in
vitro and in vivo gene delivery. They can easily be pro-
duced in large numbers, transduce a wide variety of cell
types and generate high levels of transgene expression.
The AdEasy system is a widely used, simplified system for
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ated with a minimum of enzymatic manipulations and by
employing homologous recombination in E. coli [1]. The
system consists of two adenoviral backbone vectors
(pAdEasy-1 with deleted E1/E3 and pAdEasy-2 with
deleted E1/E3/E4) and four different shuttle vectors
(pShuttle, pShuttle-CMV, pAdTrack, pAdTrack-CMV),
into which the desired transgenes are inserted. The
polylinkers are surrounded by adenoviral sequences that
allow homologous recombination with adenoviral back-
bone plasmids in E. coli. The shuttle vectors differ by
partly carrying a cytomegalievirus (CMV) promoter and
GFP as a tracer all of which contain a kanamycin resist-
ance gene. Therefore, the various components can easily
be combined depending on the desired purpose. In this
paper we describe a simplified and easy method for
screening recombinant DNA within the AdEasy system.
This Duplex-PCR-method is independent of the transgene
or insert and can be used for the complete AdEasy-System.
It is characterized by a simple standard protocol and the
results can be obtained within a few hours. The PCR is run
with two different primer sets. The primers KanaFor and
KanaRev hybridizise with the Kanamycin resistence gene
and AdFor and AdRev detect the adenoviral backbone. In
case of recombinant clones, two diagnostic fragments
with a size of 384 bp and 768 bp are generated.
Methods
The presented Duplex-PCR is performed as follows: After
Co-transformation of the Pme I-digested shuttle vector
with the adenoviral backbone plasmid to E. coli (BJ 5183)
and plating on agar (selection on kanamycin), half of the
overnight grown colonies are picked and used directly as
template for the colony-PCR. The other half of the colony
is used for inoculation with LB-kanamycin and then incu-
bation at 37°C. Only the positive, recombinant clones
which have been detected by PCR are grown overnight, a
minipreparation of DNA is then performed the next
morning.
The PCR is run using two different primer sets. The prim-
ers KanaFor (5' CAA GAT GGA TTG CAC GCA GG 3') and
KanaRev (5'AAG GCG ATA GAA GGC GAT GC 3') hybrid-
ize to the Kanamycin resistence gene and AdFor (5'GGC
TGC TCT GCT CGG AAG AC 3') and AdRev (5'GGC ATA
CGC GCT ACC CGT AG 3') detect the adenoviral
backbone.
The optimised concentrations of the components for the
Duplex-PCR were as follows: 2, 5 mM MgCl2, 100 mM
dNTPs and 0,2 Units Taq polymerase. The bacteria are
denatured at 95°C for 10 minutes. The PCR-products are
amplified by 40 cycles of annealing at 58°C (30 sec),
extension at 72°C (30 sec) and denaturation at 94°C (30
sec). In our experience, this procedure produced the best
results without generating false positive clones (Figure 1).
PCR products are analyzed by agarose gel electrophoresis,
half of the reaction volume (25 µl) is size fractionated
with 80 V for 1 h in 1% agarose in the presence of ethid-
ium bromide and the resulting bands visualized with
ultraviolet illumination.
The DNA obtained by small scale alkali lysis from the
recombinants is then extracted twice with a phenol-chlo-
roform protocol, precipitated and carefully resuspended
in 20 µl RNAse-free water. The construct is linearized with
PacI and directly transfected into 911 cells, which are
monitored for cytopathic effects, i.e. production of recom-
binant adenoviruses. The cytopathic effect is usually seen
within 5 to 10 days. The expression of the transgene is
confirmed by Western blot analysis. The practicability of
our procedure was verified with three different transgenes:
Cytosin Deaminase (AdCD), p53 (Adp53) and Granulo-
cyte Macrophage Colony Stimulating Factor (AdGM-
CSF).
Results and discussion
The conventional way of screening for recombinants after
Co-transformation of the linearized shuttle vector with
the adenoviral backbone vector in E. coli is by plating on
LB/kanamycin, growing the bacteria overnight, then pick-
ing the colonies and growing them again for 10–15 hours.
Minipreps are then performed and the size is evaluated on
agarose gels. A restriction digest with three different
restriction enzymes is then done and finally again another
agarose gel is run. This is a relatively time-consuming and
laborious procedure, which takes about 2 days.
In contrast, the presented alternative protocol allows fast
detection of recombinants with a simplified technique by
minimizing the amount of necessary steps for generating
a recombinant adenovirus. The method is time sparing
and cost-effective. In our experience, the above described
protocol showed no problems with false negative clones.
After optimisation of the PCR protocol, we were able to
run the conventional screening method (e.g. by restriction
digest) for recombinant clones at the same time as the pre-
sented simplified PCR. We found no differences in regard
to the final results for the two methods, but it has to be
kept in mind that only a limited number of recombinant
adenoviruses were actually generated with the new tech-
nique. Furthermore, we exclusively then continued our
work with the AdCD-virus. Therefore it cannot be ruled
out that under other conditions the presented technique
may produce other results than the conventional tech-
nique. The positive clones were processed and finally
transfected into 911 cells. After harvesting recombinant
adenovirus, we infected cells with AdCD and checked thePage 2 of 4
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Duplex-PCR Gel electrophoresis for PCR products from Colony Duplex PCR with two primer sets AdFor/AdRev and Kana-
For/KanaRev on AdEasy system generating two diagnostic fragments of 384 bp and 768 bp (see arrows) after homologous 
recombination.(N) negative control; (1) pShuttle/CD; (2) pAdEAsy 1; (3) pAdEasy/CD, e.g. recombinant clone
768 bp
384 bp
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expression of the Cytosin deaminase protein by Western
blot. The functionality of the gene was proven by FACS
analysis. We confirmed expression of the protein as well
as its functionality.
Conclusions
The presented protocol allows fast detection of recom-
binant clones within the AdEasy system with an easy, cost-
effective technique. Therefore, this procedure is a poten-
tial alternative for screening recombinants within the
AdEasy system.
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